White v. Saul

CourtDistrict Court, N.D. Illinois
DecidedApril 1, 2022
Docket1:19-cv-05988
StatusUnknown

This text of White v. Saul (White v. Saul) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
White v. Saul, (N.D. Ill. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

STACY W., ) ) Plaintiff, ) ) No. 19 C 5988 v. ) ) Magistrate Judge Gabriel A. Fuentes KILOLO KIJAKAZI, Acting ) Commissioner of Social Security,1 ) ) Defendant. )

MEMORANDUM OPINION AND ORDER2

Plaintiff, Stacy W.,3 applied for Disability Insurance Benefits (“DIB”) in October 2015, alleging a disability onset date of June 22, 2011 (R. 189), which was amended to July 1, 2015. (R. 36.) Plaintiff’s date last insured (“DLI”) was December 31, 2015. (R. 16.) On September 26, 2018, an Administrative Law Judge (“ALJ”) issued an opinion finding Plaintiff not disabled. The Appeals Council denied review (R. 1), making the ALJ’s decision the final decision of the

1 The Court substitutes Kilolo Kijakazi for her predecessor, Andrew Saul, as the proper defendant in this action pursuant to Federal Rule of Civil Procedure 25(d) (a public officer’s successor is automatically substituted as a party).

2 On October 28, 2019, by consent of the parties and pursuant to 28 U.S.C. § 636(c) and Local Rule 73.1, this case was reassigned to this Court for all proceedings, including entry of final judgment. (D.E. 8.)

3 The Court in this opinion is referring to Plaintiff by her first name and first initial of her last name in compliance with Internal Operating Procedure No. 22 of this Court. IOP 22 presumably is intended to protect the privacy of plaintiffs who bring matters in this Court seeking judicial review under the Social Security Act. The Court notes that suppressing the names of litigants is an extraordinary step ordinarily reserved for protecting the identities of children, sexual assault victims, and other particularly vulnerable parties. Doe v. Vill. of Deerfield, 819 F.3d 372, 377 (7th Cir. 2016). Allowing a litigant to proceed anonymously “runs contrary to the rights of the public to have open judicial proceedings and to know who is using court facilities and procedures funded by public taxes.” Id. A party wishing to proceed anonymously “must demonstrate ‘exceptional circumstances’ that outweigh both the public policy in favor of identified parties and the prejudice to the opposing party that would result from anonymity.” Id., citing Doe v. Blue Cross & Blue Shield United of Wis., 112 F.3d 869, 872 (7th Cir. 1997). Under IOP 22, both parties are absolved of making such a showing, and it is not clear whether any party could make that showing in this matter. In any event, the Court abides by IOP 22 subject to the Court’s stated concerns. Commissioner. Butler v. Kijakazi, 4 F.4th 498, 500 (7th Cir. 2021). Before the Court are Plaintiff’s motion seeking remand of that decision (D.E. 15) and the Commissioner’s cross-motion to affirm. (D.E. 17.) BACKGROUND

I. Administrative Record In June 2011, four years before her alleged onset date, Plaintiff was admitted to the emergency department (“ED”) of a local hospital after a drug overdose; she went home the next day with diagnoses of anxiety and substance abuse disorders. (R. 320-22.) In December 2011, Plaintiff was brought to the ED passed out after displaying an altered mental state either due to substance abuse or possible seizure. (R. 347-48, 661-62.) The record continues in May 2014, when Plaintiff was brought to the ED after showing an altered mental state and appearing unresponsive in a taxi; she was diagnosed with alcohol intoxication. (R. 439-41.) In June 2014, Plaintiff was again brought to the ED due to an altered mental state after a possible drug overdose; she denied using drugs, but her urine was positive for amphetamines. (R. 451-55.)

Next, on July 9, 2015, just after her alleged onset date, Plaintiff went to a walk-in clinic to report “being epileptic.” (R. 525.) She related that her friend noticed an episode where Plaintiff had a “blank stare,” and Plaintiff claimed to “have been diagnosed with petite mal seizures;” her depression and anxiety screening was negative. (R. 525-26.) Plaintiff reported that she last took medications in 2012 (Xanax, gabapentin and phenobarbital).4 (R. 526.)

4 Xanax (alprazolam) is used to treat anxiety disorders and panic disorder. https://medlineplus.gov/druginfo/meds/a684001.html. Gabapentin is used to help control certain types of seizures in people who have epilepsy. https://medlineplus.gov/druginfo/meds/a694007.html. Phenobarbital is used to control seizures, relieve anxiety and/or prevent withdrawal symptoms. See https://medlineplus.gov/druginfo/meds/a682007.html. On July 28, 2015, Plaintiff began treatment with psychiatrist Kristin Moore, M.D.; Plaintiff had no prior consistent psychiatric care. (R. 522.) Dr. Moore assessed Plaintiff with anxiety disorder and polysubstance dependence in remission and prescribed Plaintiff Prozac and hydroxyzine.5 (R. 522-23.)

On August 7, 2015, Plaintiff underwent an electroencephalogram (“EEG”) to measure the electrical activity in her brain; it showed “mild generalized slow wave abnormality.” (R. 671.) On August 13, Advanced Practice Nurse (“APN”) Suzette Rush-Drake gave her a referral for a seizure consultation with neurologist Myron Glassenberg, M.D., to review the EEG. (R. 519-21.) Plaintiff also complained of a flu bug and “back pain.” (Id.) On August 25, Plaintiff told Dr. Moore she was feeling more anxious, worried and tired, and her mood appeared anxious; Dr. Moore discontinued Prozac and prescribed Effexor and hydroxyzine.6 (R. 513-14.) On September 25, 2015, Plaintiff met with Dr. Glassenberg. She reported that her friend in July witnessed that she “stopped in the middle of conversation and got sweaty, had dark blurry vision, and stopped and stared into space for about 20 seconds and dropped what she was holding.”

(R. 574.) Plaintiff believed she had experienced additional episodes that were unwitnessed; she reported that her first seizure was in 2012 due to withdrawal from Xanax. (Id.) Dr. Glassenberg noted that the EEG “only showed some nonspecific slowing and no sharp waves.” (Id.) On examination, Plaintiff was fidgeting and had diminished upper extremity reflexes bilaterally. (R. 575-76.) Plaintiff did not want any medications. (R. 576.)

5 Prozac (fluoxetine) is used to treat depression, obsessive-compulsive disorder, and panic attacks. https://medlineplus.gov/druginfo/meds/a689006.html. Hydroxyzine is used to relieve anxiety and tension. https://medlineplus.gov/druginfo/meds/a682866.html.

6 Effexor (venlafaxine) is used to treat depression and can also used to treat generalized anxiety disorder, social anxiety disorder and panic disorder. https://medlineplus.gov/druginfo/meds/a694020.html. On October 27, 2015, Dr. Moore noted that Dr. Glassenberg found “no evidence for seizure on EEG.” (R. 499.) On examination, Plaintiff’s mood and anxiety were improved; she reported feeling more calm, levelheaded, focused and productive. (Id.) Dr. Moore increased Plaintiff’s dose of Effexor and noted that Plaintiff had not yet followed up on her referral for therapy because she

felt it was not needed. (R. 501.) The next month, on November 24, 2015, Plaintiff followed up with Dr. Moore. Plaintiff reported sleeping a little better; her anxiety was stable but her mood was sad because she was dreading being excluded by her family during the holidays. (R. 495-96.) Plaintiff did not tolerate the higher dose of Effexor, so Dr. Moore decreased the dose.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

John Doe v. Village of Deerfield
819 F.3d 372 (Seventh Circuit, 2016)
Joshua Lanigan v. Nancy A. Berryhill
865 F.3d 558 (Seventh Circuit, 2017)
Margaret Cullinan v. Nancy Berryhill
878 F.3d 598 (Seventh Circuit, 2017)
Biestek v. Berryhill
587 U.S. 97 (Supreme Court, 2019)
Christopher Jozefyk v. Nancy Berryhill
923 F.3d 492 (Seventh Circuit, 2019)
Tara Crump v. Andrew M. Saul
932 F.3d 567 (Seventh Circuit, 2019)
Jennifer Karr v. Andrew Saul
989 F.3d 508 (Seventh Circuit, 2021)
Andrew Pavlicek v. Andrew Saul
994 F.3d 777 (Seventh Circuit, 2021)
Alice Gedatus v. Andrew Saul
994 F.3d 893 (Seventh Circuit, 2021)
Dragan Kaplarevic v. Andrew Saul
3 F.4th 940 (Seventh Circuit, 2021)
Mike Butler v. Kilolo Kijakazi
4 F.4th 498 (Seventh Circuit, 2021)
Brenda Wilder v. Kilolo Kijakazi
22 F.4th 644 (Seventh Circuit, 2022)
Trisha Reynolds v. Kilolo Kijakazi
25 F.4th 470 (Seventh Circuit, 2022)
Penrod ex rel. Penrod v. Berryhill
900 F.3d 474 (Seventh Circuit, 2018)
McHenry v. Berryhill
911 F.3d 866 (Seventh Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
White v. Saul, Counsel Stack Legal Research, https://law.counselstack.com/opinion/white-v-saul-ilnd-2022.